Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

14. April 2026 13:00 ET | Quelle: DelveInsight Business Research LLP

The Psoriasis Clinical Trial Pipeline Boom as 90+ Companies are in the Race for Better Treatments | DelveInsight

New York, USA, April 14, 2026 (GLOBE NEWSWIRE) -- The Psoriasis Clinical Trial Pipeline Boom as 90+ Companies are in the Race for Better Treatments | DelveInsight The psoriasis clinical trial...
13. April 2026 13:00 ET | Quelle: DelveInsight Business Research LLP

Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight

New York, USA, April 13, 2026 (GLOBE NEWSWIRE) -- Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such...
09. April 2026 13:00 ET | Quelle: DelveInsight Business Research LLP

Acute Respiratory Distress Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 40+ Key Companies | DelveInsight

New York, USA, April 09, 2026 (GLOBE NEWSWIRE) -- Acute Respiratory Distress Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 40+ Key Companies | DelveInsight The...
08. April 2026 13:00 ET | Quelle: DelveInsight Business Research LLP

Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of Emerging Therapies | DelveInsight

New York, USA, April 08, 2026 (GLOBE NEWSWIRE) -- Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of...
07. April 2026 13:00 ET | Quelle: DelveInsight Business Research LLP

Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight

New York, USA, April 07, 2026 (GLOBE NEWSWIRE) -- Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight |...
06. April 2026 13:00 ET | Quelle: DelveInsight Business Research LLP

Idiopathic Membranous Nephropathy Market is Predicted to Reach USD 1 Billion by 2036 Due to Rising Therapeutic Options | DelveInsight

New York, USA, April 06, 2026 (GLOBE NEWSWIRE) -- Idiopathic Membranous Nephropathy Market is Predicted to Reach USD 1 Billion by 2036 Due to Rising Therapeutic Options | DelveInsight The...
02. April 2026 13:00 ET | Quelle: DelveInsight Business Research LLP

The Rise of 6 Emerging Therapies in a Critical Spinal Cord Injury Market Void | DelveInsight

New York, USA, April 02, 2026 (GLOBE NEWSWIRE) -- The Rise of 6 Emerging Therapies in a Critical Spinal Cord Injury Market Void | DelveInsight The SCI treatment pipeline continues to expand,...
01. April 2026 13:00 ET | Quelle: DelveInsight Business Research LLP

Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight

New York, USA, April 01, 2026 (GLOBE NEWSWIRE) -- Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry |...
16. März 2026 13:00 ET | Quelle: DelveInsight Business Research LLP

Pseudomonal Infections Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 10+ Leading Players Wheeling the Therapeutics Landscape

New York, USA, March 16, 2026 (GLOBE NEWSWIRE) -- Pseudomonal Infections Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 10+ Leading Players Wheeling...
09. März 2026 13:00 ET | Quelle: DelveInsight Business Research LLP

Herpes Zoster Market Poised for Robust Growth During the Forecast Period (2026–2036) Driven by Rising Incidence and Vaccine Adoption | DelveInsight

New York, USA, March 09, 2026 (GLOBE NEWSWIRE) -- Herpes Zoster Market Poised for Robust Growth During the Forecast Period (2026–2036) Driven by Rising Incidence and Vaccine Adoption | DelveInsight ...

Nächste Seite